Abstract
Background Throughout the spring of 2020, stay-at-home orders were imposed to curb the spread of COVID-19. There is limited data on the effectiveness of stay-at-home orders, particularly in rural as compared to urban areas.
Objective To examine the association between stay-at-home order implementation and the incidence of COVID-19 in rural vs. urban counties.
Design Interrupted time series analysis using a mixed effects zero-inflated Poisson model.
Participants 3,142 U.S. counties.
Interventions Stay-at-home orders.
Main Measures COVID-19 daily incidence (primary) and mobility (secondary and intermediate measure of stay-at-home effectiveness)
Key Results Stay-at-home orders were implemented later (median March 30 vs. March 28) and were shorter (median 35 vs. 54 days) in rural than urban counties. Indoor mobility was, on average, 2.6-6.9% higher in rural than urban counties both during and after stay-at-home orders. Compared to the baseline (pre-stay-at-home) period, the number of new COVID-19 cases increased under stay-at-home by IRR 1.60 (95% CI, 1.57-1.64) in rural and 1.36 (95% CI, 1.30-1.42) in urban counties. For each day under stay-at-home orders, the number of new cases changed by a factor of 0.982 (95% CI 0.981-0.982) in rural and 0.952 (95% CI, 0.951-0.953) in urban counties compared to prior to stay-at-home. Each day after stay-at-home orders expired, the number of new cases changed by a factor of 0.995 (95% CI, 0.994-0.995) in rural and 0.997 (95% CI, 0.995-0.999) in urban counties compared to prior to stay-at-home.
Conclusion Stay-at-home orders decreased mobility and slowed the spread of COVID-19, but less effectively in rural than in urban counties. This necessitates a critical reevaluation of how stay-at-home orders are designed, communicated, and implemented in rural areas.
Competing Interest Statement
The authors have no conflicts of interest to declare. In the past 36 months, Dr. McCoy also received support from an AARP Quality Measure Innovation Grant, the Mayo Clinic Center for Health Equity and Community Engagement Research, and the Mayo Clinic Robert D. and Patricia E. Kern Center for the Science of Health Care Delivery. In the past 36 months, Dr. Shah has received research support through Mayo Clinic from the Food and Drug Administration to establish Yale-Mayo Clinic Center for Excellence in Regulatory Science and Innovation (CERSI) program (U01FD005938); the Centers of Medicare and Medicaid Innovation under the Transforming Clinical Practice Initiative (TCPI); the Agency for Healthcare Research and Quality (1U19HS024075; R01HS025164; R01HS025402; R03HS025517); the National Heart, Lung and Blood Institute of the National Institutes of Health (NIH) (R56HL130496; R01HL131535); the National Science Foundation; and the Patient Centered Outcomes Research Institute (PCORI) to develop a Clinical Data Research Network (LHSNet).
Funding Statement
This effort was funded by the National Institute of Health National Institute of Diabetes and Digestive and Kidney Diseases grant K23DK114497 (McCoy) and the Mayo Clinic Research Pipeline K2R Program Award (McCoy). Study contents are the sole responsibility of the authors and do not necessarily represent the official views of NIH.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
IRB approval was not required for this study.
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Data Availability
All data used for this study are publicly available. The daily COVID-19 case data can be found at USAFacts, available at https://usafacts.org/visualizations/coronavirus-covid-19-spread-map/. Mobility data can be found from Google COVID-19 Community Mobility Data, available at https://www.google.com/covid19/mobility/. Stay-at-home orders were manually collected from news releases and official executive orders, this data is available from the authors upon request.
